Saturday 17 October 2026
Export VTR’s income statement to Excel — free account
Ventas, Inc.
VTR Real Estate Reit Healthcare Facilities
Ventas, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, up 18.5% from fiscal 2024. In the quarter to June 2026, revenue grew 21.7%, EPS fell 6.67%, free cash flow grew 13.6% and total debt fell 2.82%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for five; insiders bought in the last twelve months.
85.76
0.90
+1.06%
Follow VTR
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
33.05 | 15.69 | 50.95 | 48.52 | 41.91 | 365.14 | 0.00 | 0.00 | 309.95 | 140.69 |
Piotroski F-Score |
7 | 7 | 6 | 6 | 6 | 5 | 5 | 4 | 8 | 7 |
P/S ratio |
6.22 | 5.94 | 5.57 | 5.46 | 4.82 | 5.11 | 4.39 | 4.52 | 4.92 | 6.04 |
P/FCF ratio |
17.31 | 16.38 | 16.70 | 16.50 | 14.06 | 23.27 | 20.19 | 23.61 | 23.14 | 27.45 |
P/Operating CF |
61.44 | 61.28 | 57.37 | 59.65 | 61.91 | 73.62 | 67.83 | 72.81 | 64.90 | 74.66 |
P/B ratio |
2.03 | 1.94 | 2.03 | 2.00 | 1.78 | 1.79 | 1.77 | 2.13 | 2.24 | 2.80 |
Price to Tangible BV |
2.26 | 2.15 | 2.26 | 2.23 | 1.98 | 1.98 | 1.98 | 2.39 | 2.48 | 3.05 |
EV/Sales |
9.34 | 9.04 | 8.40 | 8.56 | 7.84 | 8.20 | 7.33 | 7.39 | 7.48 | 8.13 |
EV/EBITDA |
17.26 | 16.59 | 16.59 | 17.28 | 17.45 | 20.41 | 18.33 | 18.99 | 19.27 | 21.28 |
EV/Operating CF |
23.75 | 22.62 | 22.78 | 23.05 | 20.52 | 30.60 | 27.01 | 29.69 | 27.69 | 28.81 |
EV/FCF |
26.01 | 24.94 | 25.19 | 25.87 | 22.85 | 37.34 | 33.69 | 38.64 | 35.13 | 36.98 |
Quick Ratio |
0.37 | 0.15 | 0.53 | 0.68 | 0.85 | 0.61 | 0.62 | 0.51 | 0.85 | 0.67 |
Current Ratio |
1.08 | 1.20 | 0.53 | 0.68 | 0.85 | 0.61 | 0.62 | 0.51 | 0.85 | 0.67 |
Net Debt/EBITDA |
5.77 | 5.69 | 5.59 | 6.26 | 6.71 | 7.69 | 7.35 | 7.38 | 6.58 | 5.48 |
Debt/Assets |
48.03% | 47.07% | 47.53% | 49.24% | 49.71% | 48.66% | 50.90% | 54.56% | 51.64% | 47.16% |
Debt/Equity |
1.06 | 1.03 | 1.05 | 1.15 | 1.16 | 1.10 | 1.20 | 1.41 | 1.25 | 1.03 |
Asset Turnover |
0.15 | 0.15 | 0.16 | 0.16 | 0.16 | 0.16 | 0.17 | 0.18 | 0.19 | 0.22 |
Operating CF/Net income |
2.09 | 1.05 | 3.37 | 3.32 | 3.30 | 20.94 | (23.61) | (27.33) | 16.38 | 6.55 |
Capex/Depreciation |
(0.13) | (0.15) | (0.15) | (0.15) | (0.14) | (0.16) | (0.19) | (0.19) | (0.23) | (0.27) |
Interest Coverage |
2.32 | 2.37 | 2.23 | 1.90 | 1.31 | 0.94 | 1.08 | 0.69 | 1.13 | 1.40 |
| 6.44% | 12.64% | 3.86% | 4.16% | 4.22% | 0.46% | (0.45%) | (0.41%) | 0.80% | 2.15% | |
| 2.86% | 5.76% | 1.76% | 1.83% | 1.81% | 0.20% | (0.19%) | (0.17%) | 0.32% | 0.93% | |
ROIC |
2.86% | 3.02% | 2.96% | 2.38% | 1.77% | 1.13% | 1.41% | 1.10% | 1.82% | 2.16% |
Return on Tangible Assets |
3.17% | 6.50% | 2.10% | 2.03% | 2.16% | 0.23% | (0.23%) | (0.19%) | 0.36% | 1.06% |
Average Days of Receivables |
0.00 | 0.00 | 48.32 | 66.41 | 58.24 | 50.55 | 47.47 | 2.27 | 10.74 | 9.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
3.68% | 3.79% | 3.90% | 4.10% | 3.43% | 3.39% | 3.51% | 3.31% | 3.31% | 3.04% |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Share Based Compensation of Revenue |
0.61% | 0.74% | 0.80% | 0.88% | 0.57% | 0.84% | 0.74% | 0.69% | 0.63% | 0.66% |
Graham Net Nets |
(0.54) | (0.54) | (0.56) | (0.63) | (0.69) | (0.67) | (0.73) | (0.72) | (0.59) | (0.40) |
Graham Number |
35.94 | 51.36 | 27.31 | 27.78 | 26.92 | 9.49 | 0.00 | 0.00 | 10.60 | 18.50 |
Earnings Yield |
3.03% | 6.38% | 1.96% | 2.06% | 2.39% | 0.27% | (0.26%) | (0.22%) | 0.32% | 0.71% |
Free Cash Flow Yield |
5.78% | 6.10% | 5.99% | 6.06% | 7.11% | 4.30% | 4.95% | 4.23% | 4.32% | 3.64% |
Revenue per Share |
9.99 | 10.06 | 10.51 | 10.58 | 10.17 | 10.00 | 10.33 | 11.19 | 11.96 | 12.82 |
Operating CF per Share |
3.93 | 4.02 | 3.88 | 3.93 | 3.88 | 2.68 | 2.80 | 2.79 | 3.23 | 3.62 |
Capex per Share |
(0.34) | (0.37) | (0.37) | (0.43) | (0.40) | (0.48) | (0.56) | (0.65) | (0.68) | (0.80) |
Free Cash Flow per Share |
3.59 | 3.65 | 3.51 | 3.50 | 3.49 | 2.20 | 2.25 | 2.14 | 2.55 | 2.82 |
Cash per Share |
1.07 | 0.53 | 0.37 | 0.40 | 1.21 | 0.51 | 0.43 | 1.40 | 2.32 | 1.73 |
Shareholders Equity per Share |
30.54 | 30.77 | 28.83 | 28.81 | 27.53 | 28.60 | 25.58 | 23.75 | 26.30 | 27.66 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
30.54 | 30.77 | 28.83 | 28.81 | 27.53 | 28.60 | 25.58 | 23.75 | 26.30 | 27.66 |
Free Cash Flow |
1,237.25 | 1,296.19 | 1,249.61 | 1,281.06 | 1,301.94 | 840.84 | 898.03 | 860.46 | 1,048.01 | 1,282.86 |
Working Capital |
77.69 | 257.17 | (558.36) | (406.34) | (187.30) | (470.13) | (434.41) | (567.57) | (193.55) | (453.87) |
Capital Expenditures |
(117.46) | (132.56) | (131.86) | (156.72) | (148.23) | (185.27) | (222.13) | (259.41) | (281.61) | (363.86) |
Net Current Asset Value |
(11,568.47) | (11,487.75) | (11,685.63) | (13,296.05) | (12,594.00) | (13,045.31) | (13,228.34) | (14,589.58) | (14,255.20) | (14,076.09) |
EV/EBIT |
32.98 | 30.37 | 31.83 | 38.64 | 48.33 | 76.15 | 60.07 | 84.12 | 54.05 | 55.32 |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 |
Price to Operating Income |
21.95 | 19.95 | 21.11 | 24.63 | 29.74 | 47.45 | 36.00 | 51.41 | 35.60 | 41.07 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.06 |
Cash ROIC |
5.62% | 5.79% | 5.91% | 5.61% | 5.75% | 3.63% | 3.96% | 3.65% | 4.14% | 4.86% |
Accounts Receivable Turnover |
0.00 | 0.00 | 5.54 | 6.45 | 5.79 | 6.74 | 7.74 | 15.92 | 56.97 | 40.40 |
Accounts Payable Turnover |
0.24 | 0.23 | 0.22 | 0.26 | 0.25 | 0.25 | 0.26 | 0.30 | 0.29 | 0.27 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
1,664.50 | 1,827.31 | 1,617.32 | 1,446.65 | 1,471.32 | 1,437.82 | 1,352.13 | 1,212.98 | 1,311.66 | 1,381.56 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 676.49 | 600.24 | 655.09 | 567.85 | 533.60 | 282.53 | 86.43 | 144.39 |
Average Payables |
843.65 | 1,045.71 | 1,134.76 | 1,115.98 | 1,139.50 | 1,111.66 | 1,060.97 | 1,036.65 | 1,096.96 | 1,196.56 |
Average Assets |
22,714.26 | 23,560.57 | 23,269.55 | 23,638.38 | 24,310.81 | 24,323.60 | 24,437.82 | 24,441.64 | 25,456.17 | 26,889.43 |
Average Common Equity |
10,077.09 | 10,730.47 | 10,601.89 | 10,408.52 | 10,411.82 | 10,611.98 | 10,583.72 | 9,883.04 | 10,187.00 | 11,707.71 |
Columns are period end dates